Researchers from Baltimore-based Johns Hopkins Medicine led the study, according to a Feb. 26 news release from the health system.
The study authors are suggesting that oral prednisone, frequently used to treat heart inflammation, be used sparingly in patients with lupus to lower the risk of pericarditis recurrence.
Read the full study here.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
